(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 7.32% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Albemarle's revenue in 2025 is $4,993,278,000.On average, 26 Wall Street analysts forecast ALB's revenue for 2025 to be $590,768,318,640, with the lowest ALB revenue forecast at $561,818,317,368, and the highest ALB revenue forecast at $640,548,198,876. On average, 26 Wall Street analysts forecast ALB's revenue for 2026 to be $637,723,808,508, with the lowest ALB revenue forecast at $556,875,634,224, and the highest ALB revenue forecast at $725,515,275,780.
In 2027, ALB is forecast to generate $738,342,715,368 in revenue, with the lowest revenue forecast at $615,364,051,428 and the highest revenue forecast at $946,170,773,280.